---
description: 外泌體相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
generated_at: '2026-02-26T15:43:05.094360+00:00'
grand_parent: 外泌體
json_ld:
  '@context': https://schema.org
  '@graph':
  - '@id': https://supplement.weiqi.kids/reports/exosomes/literature/2026-02#webpage
    '@type': WebPage
    dateModified: '2026-02-26'
    datePublished: '2026-02-26'
    description: 外泌體相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
    inLanguage: zh-TW
    isPartOf:
      '@id': https://supplement.weiqi.kids#website
    name: 外泌體文獻薈萃 2026-02
    speakable:
      '@type': SpeakableSpecification
      cssSelector:
      - .article-summary
      - .speakable-content
      - .key-takeaway
      - .key-answer
      - .expert-quote
      - .actionable-steps li
      - .faq-answer-content
    url: https://supplement.weiqi.kids/reports/exosomes/literature/2026-02
  - '@id': https://supplement.weiqi.kids#organization
    '@type': Organization
    alternateName: Supplement Intelligence
    contactPoint:
      '@type': ContactPoint
      contactType: customer service
      email: info@weiqi.kids
    logo:
      '@type': ImageObject
      height: 60
      url: https://supplement.weiqi.kids/assets/images/logo.png
      width: 600
    name: 保健食品情報系統
    sameAs:
    - https://github.com/weiqi-kids/agent.supplement-product
    url: https://supplement.weiqi.kids
  - '@id': https://supplement.weiqi.kids#website
    '@type': WebSite
    name: 保健食品情報系統
    potentialAction:
      '@type': SearchAction
      query-input: required name=search_term
      target: https://supplement.weiqi.kids/search?q={search_term}
    url: https://supplement.weiqi.kids
  - '@id': https://supplement.weiqi.kids/reports/exosomes/literature/2026-02#article
    '@type': Article
    articleSection: 文獻薈萃
    author:
      '@id': https://supplement.weiqi.kids/about#person
      '@type': Person
      hasCredential:
      - '@type': EducationalOccupationalCredential
        credentialCategory: AI System
        description: 整合六大市場官方資料庫的 AI 分析系統
        name: AI 資料分析系統
      knowsAbout:
      - 保健食品市場分析
      - 膳食補充劑法規
      - 成分趨勢研究
      - 全球市場情報
      - 產品資料萃取
      name: 保健食品情報 AI
      url: https://supplement.weiqi.kids/about
    dateModified: '2026-02-26'
    datePublished: '2026-02-26'
    description: 外泌體相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
    headline: 外泌體文獻薈萃 2026-02
    inLanguage: zh-TW
    isAccessibleForFree: true
    isPartOf:
      '@id': https://supplement.weiqi.kids#website
    keywords: 外泌體,文獻回顧,學術研究,證據分析
    mainEntityOfPage:
      '@id': https://supplement.weiqi.kids/reports/exosomes/literature/2026-02#webpage
    publisher:
      '@id': https://supplement.weiqi.kids#organization
    wordCount: 579
  - '@type': BreadcrumbList
    itemListElement:
    - '@type': ListItem
      item: https://supplement.weiqi.kids
      name: 首頁
      position: 1
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/exosomes
      name: 外泌體
      position: 2
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/exosomes/literature
      name: 文獻薈萃
      position: 3
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/exosomes/literature/2026-02
      name: 2026-02
      position: 4
  - '@id': https://supplement.weiqi.kids/reports/exosomes/literature/2026-02#primaryimage
    '@type': ImageObject
    creditText: 保健食品情報系統
    height: 630
    license: https://creativecommons.org/licenses/by-nc/4.0/
    representativeOfPage: true
    url: https://supplement.weiqi.kids/assets/images/og-default.png
    width: 1200
layout: default
nav_order: 202602
parent: 文獻薈萃
title: 外泌體文獻薈萃 2026-02
topic: exosomes
total_articles: 10565
---

# 外泌體文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 外泌體 相關文獻 10565 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）269 篇，RCT 42 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 269 | 2.5% |
| Level 2 (RCT) | 42 | 0.4% |
| Level 3 (Clinical Trial) | 50 | 0.5% |
| Level 4 (Observational) | 36 | 0.3% |
| Level 5 (Review/Case Report/Other) | 10168 | 96.2% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| immune | 免疫調節 | 4119 | 39.0% |
| other | 其他 | 3027 | 28.7% |
| musculoskeletal | 肌肉骨骼 | 2206 | 20.9% |
| anti_aging | 抗衰老 | 1476 | 14.0% |
| cardiovascular | 心血管 | 1182 | 11.2% |
| metabolic | 代謝 | 1163 | 11.0% |
| cognitive | 認知功能 | 1134 | 10.7% |
| skin | 皮膚 | 839 | 7.9% |
| digestive | 消化 | 593 | 5.6% |
| energy | 活力 | 202 | 1.9% |
| sexual | 性功能 | 183 | 1.7% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| stem cell | 5097 |
| EPA | 2212 |
| iron | 1887 |
| exosome | 1781 |
| exosomes | 1491 |
| collagen | 493 |
| calcium | 206 |
| fiber | 156 |
| NAC | 141 |
| hyaluronic acid | 91 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| exosome + exosomes | 1491 |
| EPA + stem cell | 1300 |
| iron + stem cell | 843 |
| exosome + stem cell | 562 |
| exosomes + stem cell | 518 |
| EPA + iron | 492 |
| EPA + exosome | 466 |
| EPA + exosomes | 391 |
| exosome + iron | 380 |
| exosomes + iron | 308 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 免疫調節 | 肌肉骨骼 | 其他 | 抗衰老 | 皮膚 | 心血管 |
|------|--------|--------|--------|--------|--------|--------|--------|
| stem cell | 5097 | 1931 | 1450 | 1373 | 746 | 474 | 437 |
| EPA | 2212 | 1044 | 699 | 455 | 321 | 271 | 256 |
| iron | 1887 | 1134 | 457 | 305 | 272 | 153 | 238 |
| exosome | 1781 | 946 | 336 | 338 | 247 | 198 | 331 |
| exosomes | 1491 | 788 | 290 | 294 | 200 | 173 | 281 |
| collagen | 493 | 224 | 191 | - | 85 | 493 | 36 |
| calcium | 206 | 82 | 110 | 27 | 25 | 25 | 32 |
| fiber | 156 | 54 | 72 | 18 | 24 | 41 | 14 |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 102 | 1.0% |
| Systematic Review | 167 | 1.6% |
| RCT | 42 | 0.4% |
| Clinical Trial | 50 | 0.5% |
| Observational | 36 | 0.3% |
| Review | 2765 | 26.2% |
| Case Report | 380 | 3.6% |
| Other | 7023 | 66.5% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[Molecular Markers of Tumor Invasion in Ameloblastoma: A Systematic Review.](https://pubmed.ncbi.nlm.nih.gov/41146411/)** — Oral diseases, 2025-10-27
   - 功效分類：immune, musculoskeletal

2. **[Primary and secondary stroke prophylaxis in children with sickle cell anemia: a meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41071946/)** — Blood advances, 2026-02-10
   - 功效分類：other

3. **[Prognostic Biomarkers for Predicting Decompensation in Alcoholic and Nonalcoholic Patients With Compensated Cirrhosis: An Umbrella Review.](https://pubmed.ncbi.nlm.nih.gov/41635504/)** — Biochemistry research international, 2026-01-01
   - 功效分類：anti_aging

4. **[Regenerative Medicine for Atrophic Scars: A Systematic Review of Extracellular Vesicles, Conditioned Media, Stromal Vascular Fraction, and Mesenchymal Stem Cells.](https://pubmed.ncbi.nlm.nih.gov/41099835/)** — Aesthetic plastic surgery, 2025-10-16
   - 功效分類：skin

5. **[Respiratory oscillometry in monitoring lung transplant allograft function: a systematic scoping review.](https://pubmed.ncbi.nlm.nih.gov/41534887/)** — European respiratory review : an official journal of the European Respiratory Society, 2026-01-01
   - 功效分類：other


### Level 2 證據（RCT）

1. **[Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma.](https://pubmed.ncbi.nlm.nih.gov/41701105/)** — Journal of medical economics, 2026-12-01
   - 功效分類：other

2. **[Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.](https://pubmed.ncbi.nlm.nih.gov/41347825/)** — Blood, 2026-02-12
   - 功效分類：other

3. **[Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional decline.](https://pubmed.ncbi.nlm.nih.gov/40366127/)** — Food & function, 2025-06-03
   - 功效分類：cognitive, immune

4. **[Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson's disease clinical trial.](https://pubmed.ncbi.nlm.nih.gov/40993774/)** — Stem cell research & therapy, 2025-09-24
   - 功效分類：anti_aging, immune, musculoskeletal

5. **[Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.](https://pubmed.ncbi.nlm.nih.gov/41331725/)** — Stem cell research & therapy, 2025-12-02
   - 功效分類：immune, skin



---

<div class="disclaimer" markdown="1">

**免責聲明**

本網站內容由 AI 自動生成，基於各國官方公開資料庫的產品登記資訊。
報告內容僅供參考，不構成醫療建議、投資建議或商業建議。
如有健康問題，請諮詢專業醫療人員。

產品統計以資料庫登記為準，不代表實際市場銷售狀況。
各國監管制度不同，跨國比較應考慮法規差異。

</div>
